Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Clinical trial NCT01875874 · TERMINATED

Trial details

NCT number: NCT01875874
Sponsor: Vital Therapies, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Liver Failure Fulminant Hepatic Failure Primary Graft Non-Function Surgically-Induced Liver Failure

Start date: 2014-10-01
Primary completion: 2015-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.